secwatch.observer — SEC 8-K summary
======================================

Issuer:     DiaMedica Therapeutics Inc. (DMAC)
CIK:        0001401040
Form:       8-K
Filed at:   2025-07-21T23:59:59+00:00
Accession:  0001437749-25-023048
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DiaMedica raises $30.1M via private placement of 8.6M shares at $3.50 to fund preeclampsia pipeline
--------------------------------------------------------------------------------

- Private placement of 8,606,426 common shares at $3.50 per share, raising $30.1M gross proceeds.
- Closing expected July 23, 2025; no placement agent engaged.
- Proceeds to support DM199 IND submission and Phase 2b study for preeclampsia and fetal growth restriction.
- Registration rights agreement requires filing resale registration statement within 10 business days of closing.
- Transaction involves non-management related parties; exempt from Canadian MI 61-101 valuation/minority approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401040/000143774925023048/0001437749-25-023048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401040/000143774925023048/dmtp20250720_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-023048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer